All Pharma News
Xenon Pharma at RBC Healthcare Conference 2024

Xenon Pharma at RBC Healthcare Conference 2024
GLOBENEWSWIRE
06 May 2024
Share Share
Xenon Pharmaceuticals to Present at Bloom Burton & Co. Conference

Xenon Pharmaceuticals to Present at Bloom Burton & Co. Conference
GLOBENEWSWIRE
10 Apr 2024
Share Share
Xenon Pharma Announces Closing of $345.0 Million Upsized Public Offering

Xenon Pharma Announces Closing of $345.0 Million Upsized Public Offering
GLOBENEWSWIRE
04 Dec 2023
Share Share
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs
GLOBENEWSWIRE
02 Dec 2023
Share Share
Xenon offers $300M in shares after touting path ahead for MDD program

Xenon offers $300M in shares after touting path ahead for MDD program
ENDPTS
30 Nov 2023
Share Share
Xenon Pharmaceuticals Announces Proposed Public Offering

Xenon Pharmaceuticals Announces Proposed Public Offering
GLOBENEWSWIRE
29 Nov 2023
Share Share
Xenon Pharma Announces Pricing of Upsized $300.0 Million Public Offering

Xenon Pharma Announces Pricing of Upsized $300.0 Million Public Offering
GLOBENEWSWIRE
29 Nov 2023
Share Share
Xenon`s MDD med fails ph. 2, elevating seizure potential

Xenon`s MDD med fails ph. 2, elevating seizure potential
Max Bayer FIERCE BIOTECH
28 Nov 2023
Share Share
Xenon Announces Topline Results from Phase 2 X-NOVA Trial of XEN1101

Xenon Announces Topline Results from Phase 2 X-NOVA Trial of XEN1101
GLOBENEWSWIRE
27 Nov 2023
Share Share
Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry

Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry
BIOSPACE
11 Nov 2023
Share Share